Assessment of pain quality in a clinical trial of gabapentin extended release for postherpetic neuralgia

Clinical Journal of Pain

Volumn 25, Issue 4, 2009, Pages 286-292

  Jensen, Mark P ^a   Chiang, Yu Kun ^b   Wu, Jacqueline ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Essence Sciences   (United States)

^c WuMW   (United States)

Author keywords

Neuropathic pain; Neuropathic Pain Scale; Pain assessment; Pain quality; Postherpetic neuralgia

Indexed keywords

GABAPENTIN; PLACEBO;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG RELEASE; EVENING DOSAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NEUROPATHIC PAIN; NOCICEPTION; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 67649562986     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318192bf87     Document Type: Article

References (22)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353: 1959-1964.
2. Woolf CJ, Max MB. Mechanism-based pain diagnosis. Anesthesiology. 2001;95:241-249.
3. Jensen TS, Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain. 2003;102:1-8.
4. Jensen MP. Review of measures of neuropathic pain. Curr Pain Headache Rep. 2006;10:159-166.
5. Jensen MP. Using pain quality assessment measures for selecting analgesic agents. Clin J Pain. 2006;22:S9-S13.
6. Jensen MP, Friedman M, Bonzo D, et al. The validity of the Neuropathic Pain Scale for assessing diabetic neuropathic pain in a clinical trial. Clin J Pain. 2006b;22:97-103.
7. Chang PF, Arendt-Nielsen L, Graven-Nielsen T, et al. Comparative EEG activation to skin pain and muscle pain induced by capsaicin injection. Int J Psychophysiol. 2004;51:117-126.
8. Geha PY, Baliki MN, Chialvo DR, et al. Brain activity for spontaneous pain of postherpetic neuralgia and its modulation by lidocaine patch therapy. Pain. 2007;128:88-100.
9. Jensen MP, Gammaitoni AR, Olaleye DO, et al. The Pain Quality Assessment Scale (PQAS): assessment of pain quality in carpal tunnel syndrome. J Pain. 2006;7:823-832.
10. Jensen MP, Dworkin RH, Gammaitoni AR, et al. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain. 2005;6:98-106.
11. Lynch ME, Clark AJ, Sawynok J. Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. Pain. 2003;103:111-117.
12. Weissenbacher S, Ring J, Hofmann H. Gabapentin for the symptomatic treatment of chronic neuropathic pain in patients with late-stage lyme borreliosis: a pilot study. Dermatology. 2005;211:123-127.
13. Tai Q, Kirshblum S, Chen B, et al. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spin Cord Med. 2002;25:100-105.
14. Levendoglu F, Ogun CO, Ozerbil O, et al. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine. 2004;29:743-751.
15. Irving G, Jensen MP, Cramer M, et al. Efficacy and tolerability of gastric-retentivet gabapentin for the treatment of postherpetic neuralgia: results of a phase 2 double-blind, randomized clinical trial. J Pain. 2009. In press.
16. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997;48:332-338.
17. Galer BS, Jensen MP, Ma T, et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain. 2002;18:297-301.
18. Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symp Manag. 2004;28:396-411.
19. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191-197.
20. Krause SJ, Backonja MM. Development of a Neuropathic Pain Questionnaire. Clin J Pain. 2003;19:306-314.
21. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain. 2004;108:248-257.
22. Jensen MP, McFarland CA. Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain. 1993;55:195-203.